Treatment with Crexont statistically significantly improved “On” time without troublesome dyskinesia compared with carbidopa/levodopa IR. The Food and Drug Administration (FDA) has approved Crexont ® ...

Learn everything you need to know about Carbidopa-Levodopa-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

SPID ®-Technology utilizes compartmentalization to enable sequential release of carbidopa and levodopa, offering a potential new approach for drug delivery in Parkinson’s disease treatment. "Levodopa ...

Clinicians should monitor vitamin B6 levels in Parkinson disease patients taking carbidopa/levodopa due to a risk for deficiency-linked seizures. Reports of seizures linked to vitamin B6 deficiency in ...

The FDA issued a safety communication today warning of a potential increased risk of seizures tied to certain medications used to treat Parkinson's disease. The agency will require manufacturers of ...

The FDA approved an oral extended-release formulation of levodopa and carbidopa known as IPX203 (Crexont) to treat Parkinson's disease, Amneal Pharmaceuticals announced Wednesday. The treatment is a ...

If you have advanced Parkinson’s disease (PD), you may hear about a treatment option called Vyalev (foscarbidopa/foslevodopa). It was approved by the FDA in 2024 ...

Levodopa/carbidopa/entacapone (Stalevo) is currently available in dose formulations of 50 mg/12.5 mg/200 mg, 100 mg/25 mg/200 mg, and 150 mg/37.5 mg/200 mg. Each ...

There have been many remarkable changes in treatments for Parkinson's disease in recent years. Scientists have developed new drugs, and they have a better understanding of how to use older treatments.

Review the side-effects of Carbidopa-Levodopa as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority ...